April 02, 2025

Unequal Access Worsens Opioid Crisis for Black Patients

Despite rising opioid overdose rates among Black patients, systemic barriers and unequal access to treatment continue to hinder recovery efforts and worsen outcomes.

KFF Health News

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 27, 2025

FDA Examines Stimulant Use Trends

The FDA reviews rising adult prescription stimulant use, ongoing shortages, and efforts to ensure appropriate access and minimize nonmedical use.

Conexiant

March 24, 2025

New State Model for Psilocybin Therapy

Read about the emergence of state-regulated psychedelic mushrooms in Colorado and their potential therapeutic applications.

KFF Health News

March 18, 2025

Medtronic Recall: FDA Issues Highest-Risk Warning

The FDA has classified the recall of Medtronic’s Pipeline Vantage embolization devices as its most serious, citing risks of thrombosis, stroke, and death. The devices, used to treat brain aneurysms, have been linked to multiple patient injuries and fatalities.

Reuters

March 14, 2025

FDA Warns of Nitrous Oxide Misuse

The FDA warns of serious health risks associated with non-medical use of nitrous oxide, highlighting neurological damage, thromboembolic events, and death.

Reuters

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 07, 2025

CDC Plans Study on Autism Causes

The CDC is launching a large-scale study on autism prevalence and potential contributing factors. Previous research has found no causal link between vaccines and autism, though diagnoses have risen due to expanded screening and diagnostic criteria.

Reuters